11-68903928-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_002180.3(IGHMBP2):​c.-25C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 1,595,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

IGHMBP2
NM_002180.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.216

Publications

0 publications found
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
MRPL21 (HGNC:14479): (mitochondrial ribosomal protein L21) Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Multiple transcript variants encoding different isoforms were identified through sequence analysis although some may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 11-68903928-C-T is Benign according to our data. Variant chr11-68903928-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 389694.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000322 (49/152254) while in subpopulation AMR AF = 0.00222 (34/15286). AF 95% confidence interval is 0.00164. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGHMBP2NM_002180.3 linkc.-25C>T 5_prime_UTR_variant Exon 1 of 15 ENST00000255078.8 NP_002171.2 P38935
MRPL21NM_181514.2 linkc.-118G>A upstream_gene_variant ENST00000362034.7 NP_852615.1 Q7Z2W9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGHMBP2ENST00000255078.8 linkc.-25C>T 5_prime_UTR_variant Exon 1 of 15 1 NM_002180.3 ENSP00000255078.4 P38935
MRPL21ENST00000362034.7 linkc.-118G>A upstream_gene_variant 1 NM_181514.2 ENSP00000354580.2 Q7Z2W9-1

Frequencies

GnomAD3 genomes
AF:
0.000322
AC:
49
AN:
152254
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00222
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000216
AC:
45
AN:
208146
AF XY:
0.000211
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000693
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000323
Gnomad NFE exome
AF:
0.000190
Gnomad OTH exome
AF:
0.000188
GnomAD4 exome
AF:
0.000201
AC:
290
AN:
1443374
Hom.:
0
Cov.:
33
AF XY:
0.000201
AC XY:
144
AN XY:
716668
show subpopulations
African (AFR)
AF:
0.0000303
AC:
1
AN:
33020
American (AMR)
AF:
0.000601
AC:
25
AN:
41606
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25748
East Asian (EAS)
AF:
0.0000772
AC:
3
AN:
38862
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
84542
European-Finnish (FIN)
AF:
0.000177
AC:
9
AN:
50952
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5728
European-Non Finnish (NFE)
AF:
0.000214
AC:
236
AN:
1103296
Other (OTH)
AF:
0.000218
AC:
13
AN:
59620
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000322
AC:
49
AN:
152254
Hom.:
0
Cov.:
35
AF XY:
0.000417
AC XY:
31
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41470
American (AMR)
AF:
0.00222
AC:
34
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68044
Other (OTH)
AF:
0.000955
AC:
2
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000139
Hom.:
0
Bravo
AF:
0.000230

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 20, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
7.9
DANN
Benign
0.81
PhyloP100
0.22
PromoterAI
0.087
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780273172; hg19: chr11-68671396; API